• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. LXC12; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. LXC12; ANTI-REFLUX IMPLANT Back to Search Results
Model Number LXC-[14]
Device Problems Migration or Expulsion of Device (1395); Device Appears to Trigger Rejection (1524); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Chest Pain (1776); Dysphagia/ Odynophagia (1815); Pocket Erosion (2013); Weight Changes (2607)
Event Date 06/24/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).Date sent; (b)(6) 2022 unknown; captured as awareness date.No lot number was provided therefore a device history could not be done.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent: what is the product code of the linx device? what is the lot number? what was the date of implant? if the device has been removed, what was the date of explant? what were the first clinical symptoms that provided evidence of an erosion and when did they first occur? has the patient had any dilations, egd, or other procedure between the linx implant and discovery of the erosion? please describe and include the dates of the procedures.Are pictures or videos available? how many beads eroded? where were the eroded beads positioned? which best describes the device removal approach? endoscopically removed the eroded beads initially & laparoscopically removed the device at a later date endoscopically removed the eroded beads & laparoscopically removed the device the same day endoscopically removed the entire device laparoscopically removed the entire device was the patient stented? what is the current condition of the patient?.
 
Event Description
It was reported that there was a linx device erosion with planned explant.Patient lost 50 lbs.Explant may take place.No additional information was received.
 
Manufacturer Narrative
(b)(4), date sent: 7/7/2022.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Linx photo images were received and are pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Additional information was requested, and the following was obtained: what is the product code of the linx device? lxc-14.What is the lot number? 6452 sr#7845.What was the date of implant? (b)(6) 2014.If the device has been removed, what was the date of explant? patient was referred to osu services of (b)(6).What were the first clinical symptoms that provided evidence of an erosion and when did they first occur? dysphagia.Has the patient had any dilations, egd, or other procedure between the linx implant and discovery of the (b)(6) 2022 esophageal manometry, (b)(6) 2021 egd, (b)(6) 2019 egd evaluation under fluro/bravo capsule, (b)(6) 2018 egd/bravo erosion? please describe and include the dates of the procedures.Are pictures or videos available? pictures were taken how many beads eroded? 3.Where were the eroded beads positioned? distal.Which best describes the device removal approach? this patient was referred to osu endoscopically removed the eroded beads initially & laparoscopically removed the device at a later date, endoscopically removed the eroded beads & laparoscopically removed the device the same day, endoscopically removed the entire device, laparoscopically removed the entire device.Was the patient stented? what is the current condition of the patient? patient was stable when they left our facility.Additional information provided: erosion discovered during egd on (b)(6) 2022.Removal on (b)(6) 2022.Egd report attached 56 yo male, initials (b)(6), general health¿cardiac issues.Patient has been seen annually for follow up after linx.Has done well post linx, last check was sep 2021¿egd clear, fluoro showed device in good position.Patient experienced chest pain, painful, difficult swallowing, x2 months.Lost 50lbs--could only eat chicken soup and suck on crackers.Manometry (b)(6) 2022 with no change.Had to wait for cardiac clearance for anesthesia before doing egd.Egd on (b)(6) 2022 showed 3 beads in the lumen (see attached report).Patient referred to (b)(6), (b)(6) (experienced linx surgeon) for removal.Coordinator will call patient tomorrow and provide update on status.
 
Manufacturer Narrative
(b)(4), date sent: 8/17/2022.Photo analysis: as per medical safety officer: "the endoscopy report describes device erosion and device location below the diaphragm.The photographs demonstrate the linx beads visible within the lumen of the esophagus".Hands-on analysis of the device is necessary to determine the cause of esophageal erosion.A manufacturing record evaluation was performed for the finished device batch number 6452, and no non-conformances were identified.Additional information received: the dhr for lot number 6452 states product code 3718-12, which is lxc12.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LXC12
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
Manufacturer Contact
orla o'mahony
4188 lexington avenue north
shoreview 55126
MDR Report Key14854885
MDR Text Key294942109
Report Number3008766073-2022-00133
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005134
UDI-Public00855106005134
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 08/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/15/2018
Device Model NumberLXC-[14]
Device Catalogue NumberLXC12
Device Lot Number6452
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received08/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/15/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
Patient SexMale
-
-